Berberine para Insulin Resistance
A Evidencia Múltiples ensayos clínicos de gran tamaño muestran de forma consistente beneficios significativos.Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.
Conclusión
Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.
Key Study Findings
Población: Women with PCOS and insulin resistance
Población: None
Población: Obese population (herbal medicine review)
Población: Healthy individuals
Población: None
Población: HFD-induced NAFLD rat model
Key Statistics
27
Estudios
2500
Participantes
Positive
Calificación
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Dosificaciones de uso común
- general:
- 500 mg 2-3x/day with meals
- starting:
- 500 mg/day and titrate
- metabolicsupport:
- 1,000-1,500 mg/day
Límite superior: 1,500 mg/day; GI side effects limit intake; potential drug interactions
Dosificaciones estudiadas en la investigación
| Dosificación | Duración | Efecto | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Various herbal medicines | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
Mejor momento para tomar: With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)
Safety & Side Effects
Efectos secundarios reportados
- ⚠ Diarrhea
- ⚠ Constipation
- ⚠ Flatulence
- ⚠ Abdominal pain
- ⚠ Potential hypoglycemia (when combined with diabetes medications)
Interacciones conocidas
- ● Diabetes medications (may potentiate — hypoglycemia risk)
- ● CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
- ● CYP2D6 substrates
- ● Cyclosporine
- ● Metformin (additive effects)
Ingesta máxima tolerable: 1,500 mg/day; GI side effects limit intake; potential drug interactions
Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.
Frequently Asked Questions
Does Berberine help with Insulin Resistance?
How much Berberine should I take for Insulin Resistance?
Are there side effects of Berberine?
How strong is the evidence for Berberine and Insulin Resistance?
Related Evidence
Otros ingredientes para Insulin Resistance
Berberine para otras condiciones
References
- [1] Daniela Ciobârcă et al.. Pharmaceuticals (Basel). 2025. Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. doi:10.3390/ph18020279 PubMed
- [2] Lin Yin et al.. Front Nutr. 2025. The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in polycystic ovary syndrome. doi:10.3389/fnut.2025.1700612 PubMed
- [3] Qiao Zhang et al.. J Ethnopharmacol. 2023. Role of herbal medicine and gut microbiota in the prevention and treatment of obesity. doi:10.1016/j.jep.2022.116127 PubMed
- [4] Ayoub Amssayef et al.. Curr Pharm Des. 2023. Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review. doi:10.2174/0113816128270340231121043038 PubMed
- [5] Ting-Wei Zhu et al.. Clin Exp Pharmacol Physiol. 2023. Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome. doi:10.1111/1440-1681.13814 PubMed
- [6] Mingyue Zhong et al.. Food Funct. 2022. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. doi:10.1039/d2fo01009g PubMed
- [7] Shi-Jun Yue et al.. Am J Physiol Endocrinol Metab. 2019. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. doi:10.1152/ajpendo.00256.2018 PubMed
Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.